Key Takeaways

  • Campaign Crafters Media: ASTP/ONC data indicates that 76% of U.S. nonfederal acute-care hospitals participated in all four interoperability domains in 2025, giving buyers a useful baseline for evaluating HL7 FHIR, C-CDA, and ADT capabilities.
  • A practical rollout usually starts with one measurable workflow, such as reconciling external laboratory results or publishing a daily capacity dashboard from the electronic health record.
  • Buyers should test data lineage, patient matching, refresh latency, and role-based access before comparing dashboard design or AI-assisted reporting features.
  • External communications partners should receive governed, aggregate data (not row-level protected health information) and should be included in metric approval and publication controls.

Define the Operational Problem Before Selecting a Platform

A patient arrives at a D.C.-metro emergency department after receiving laboratory work elsewhere, but the result is not visible in the local electronic health record, or EHR. Staff call the originating facility, the clinician delays a decision, and the patient may undergo the test again. That is an analytics problem, but it begins with incomplete exchange and inconsistent identity data rather than a missing chart.

The scale is visible in federal research. ASTP/ONC reported that 76% of nonfederal acute-care hospitals engaged in sending, receiving, finding, and integrating health information in 2025, while 79% integrated received information into their EHRs. Separate ASTP/ONC findings for 2024 showed that 20% of people who saw a provider waited longer than they considered reasonable for test results, while 10% repeated a test because the earlier result was unavailable.

Buyers should therefore define a workflow and its failure condition. Examples include an admission, discharge, and transfer (or ADT) feed arriving more than 15 minutes late; Logical Observation Identifiers Names and Codes, or LOINC, failing to map into the laboratory dashboard; or duplicate patient records preventing an external result from entering the correct chart.

Reporting also extends beyond clinical operations. Communications teams may need approved, aggregate views for public-health messaging or service-line education. A firm such as Campaign Crafters Media can consume governed summary data, but should not receive row-level protected health information, or PHI, or direct access to the clinical warehouse.

Evaluate the Data Layer, Not Just the Dashboard

Platform evaluation should begin with the systems beneath the visualization layer: Epic or Oracle Health EHR databases, CRISP feeds, laboratory interfaces, claims files, scheduling systems, and patient-experience data.

Require vendors to demonstrate ingestion of Health Level Seven version 2, or HL7 v2, ADT messages; Consolidated Clinical Document Architecture, or C-CDA, documents; and HL7 Fast Healthcare Interoperability Resources, or FHIR R4, such as Patient, Encounter, Observation, and DiagnosticReport. Buyers should also ask how the platform maps those records to the United States Core Data for Interoperability, or USCDI, which defines standardized health-data classes and elements. For batch sources, ask whether the platform accepts CSV, Parquet, and X12 837 or 835 files through secure file transfer protocol, REST application programming interfaces, or managed integration engines.

Patient matching deserves its own test. A platform should explain how it handles changes in surname, address, phone number, and medical record number; whether it uses deterministic matching based on exact rules or probabilistic matching based on weighted similarities; and how uncertain matches reach a human review queue.

Regional context also plays a role in data strategy. The Chesapeake Regional Information System for our Patients, known as CRISP, serves Maryland and D.C., while systems such as MedStar Health and Inova Health System operate across jurisdictional boundaries. A buyer may need to normalize facility identifiers, consent status, and public-health reporting rules before producing a single regional view.

Analytics priorities also extend beyond interoperability. In Milliman MedInsight’s 2025 Provider Market Survey, 62% of value-based-care provider organizations prioritized cost and utilization analysis and 62% prioritized improving clinical care, while also citing EHR and clinical-data integration as a top analytics-platform priority. The same survey found that 52% cited data quality or interoperability as an analytics and AI-adoption barrier, and 38% reported difficulty integrating advanced analytics with existing IT systems.

Plan the Rollout Around Traceable Data

During discovery, the clinical owner, analytics lead, interface engineer, privacy officer, and data steward should document one report from source field to final metric. If an emergency-department dashboard defines arrival differently from the EHR’s operational report, the disagreement should be resolved before migration.

The build phase typically includes a raw ingestion zone, a validated clinical model, and a reporting layer. A common architecture might place HL7 and FHIR data in cloud object storage, transform it with SQL or dbt, load curated tables into Snowflake or Azure SQL, and expose measures through Microsoft Power BI or Tableau. Product names matter less than reproducible data lineage, the recorded path from source field through each transformation, and enforceable access controls.

Before broader release, teams should run parallel reports and reconcile totals by facility, encounter type, and date. They should also test FHIR API throttling, late-arriving ADT events, daylight-saving timestamps, null values, and interrupted interface-engine connections. Those edge cases are routine, but they often determine whether clinicians trust the dashboard.

National exchange is expanding quickly. An October 2026 HHS Office of the Assistant Secretary for Planning and Evaluation review of data sharing and interoperability reported that nearly 500 million health records had moved through the Trusted Exchange Framework and Common Agreement, or TEFCA, by February 2026, compared with roughly 10 million in January 2025. TEFCA establishes a nationwide policy and technical framework for exchange among participating health-information networks. Buyers should ask whether a proposed architecture can preserve provenance (where each record originated) and consent metadata as external record volume grows.

Decide What Outcomes to Measure

Post-launch measurement should focus on observable workflow changes rather than login counts alone. Useful indicators include the median delay between a finalized laboratory result and dashboard availability, the number of unresolved patient matches, repeated-test frequency, report-reconciliation exceptions, and time spent preparing public-health submissions.

For quality reporting, teams can compare numerator and denominator values against source EHR queries. For operational dashboards, they can monitor data freshness by interface and facility. A red status for an ADT feed that has not updated in 30 minutes gives staff a specific condition to investigate, unlike a general system health indicator.

Health information organization, or HIO, capabilities offer another benchmark. The 2025 National HIO Survey found that 88% of surveyed organizations connected to at least one state, local, or tribal public-health agency, while 45% offered dashboard or data-visualization assistance and 45% provided analytics or data-quality support. Those figures suggest that exchange partners may contribute more than transport, although buyers should confirm service scope and data-use terms.

Turn Governance Into a Working Routine

Governance should produce decisions, not merely policies. A monthly data-quality meeting can review unmapped LOINC codes, duplicate-record queues, failed interface messages, and disputed measure definitions. Each issue needs an owner, source-system reference, and resolution status in Jira, ServiceNow, or a comparable ticketing system.

When analytics inform patient outreach or external communications, Campaign Crafters Media and similar partners should receive approved aggregate exports with suppression rules for small cohorts. The healthcare provider retains control of metric definitions, HIPAA review, and publication approval.

AI-assisted analysis adds another review layer. Research published on intersystems.com identifies FHIR, TEFCA, data governance, predictive modeling, and population-health analytics as foundations for moving from basic interoperability to clinical workflows that use exchanged data. Buyers evaluating natural-language queries or generated summaries should test citation back to source tables, prompt logging, role-based permissions, and human approval for clinical interpretations.

Apply the Model Beyond Large Health Systems

Community hospitals and specialty groups can start with one FHIR endpoint, one SQL reporting model, and a limited dashboard audience. The same approach applies: trace each measure to its source, validate identity matching, and expand only after users can reconcile the numbers.

How long does a healthcare analytics implementation take?

Timing depends on interface readiness and measure complexity, so a buyer should estimate by phase rather than promise a fixed duration. Connecting an existing FHIR R4 endpoint may be relatively contained, while normalizing HL7 v2, claims, laboratory, and CRISP data can require several months of mapping, validation, and privacy review.

What should we ask a healthcare analytics vendor to demonstrate?

Ask for a live trace from an HL7 Observation or FHIR DiagnosticReport through transformation logic to a dashboard measure. The demonstration should also show row-level security, audit logs, failed-message handling, data-refresh timestamps, and the workflow for reviewing uncertain patient matches.

Is a data warehouse required for healthcare reporting?

Not for every use case. A limited operational dashboard may query an EHR reporting database or FHIR API, but cross-system quality measurement often benefits from curated SQL tables in a warehouse or lakehouse. Buyers should base the decision on source count, refresh requirements, historical retention, and the need to reproduce prior submissions.